University Rovira i Virgili
Tarragona, 43007, Spain
NCT Number: NCT05167110
Based on alterations in the intestinal microbiota in children with ASD and the high comorbidity between ASD and ADHD, the aim of this project was to assess whether the administration of probiotics with strains related to the production of the neurotransmitters dopamine and GABA had a positive effect on social behavior, attention, and behavior.
Looking for future studies?
Notify Me4 year–16 year
All sexes
Interventional
Not applicable
Tarragona, 43007, Spain
We hypothesized to find differences in the composition and / or function of the microbiota of the gastrointestinal tract of children with ASD and / or ADHD. We consider that the intervention with probiotics (and specifically with GABA and dopamine producing strains), can modify the composition and / or function of the GIT microbiota and change the child's behavior, partially reducing the symptoms of attention deficit, anxiety, irritability, impulsivity and restlessness associated with diagnoses and consequently, we believe that it could improve the quality of life for children and their families. Apart from the clinical evaluation of the disorder and associated psychopathological symptoms and neuropsychological deficit, the diet, lifestyle and anthropometric characteristics of the child will be evaluated, which can influence the composition and / or function of gut the microbiota.
The sample that will be part of the study will be 80 children, 40 with a diagnosis of ASD and 40 with a diagnosis of ADHD. These children will randomly receive placebo or probiotic intervention for 12 weeks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Children assigned to the groups (ASD/ADHD) will be randomly prescribed placebo supplementation for 12 weeks (placebo subgroup).
Children assigned to the groups (ASD/ADHD) will be randomly prescribed supplementation with two GABA- and dopamine-producing strains at a total of 1 x 10 (9) CFU/capsule for 12 weeks (probiotic subgroup).
Time frame: 12 weeks
Measures attention and inhibitory control
Time frame: 12 weeks
Assess severity of the ASD manifestations answered by parents
Time frame: 12 weeks
Assess severity ADHD symptoms answered by parents
Time frame: 12 weeks
Assess severity ADHD symptoms answered by parents
Time frame: 12 weeks
Time frame: 12 weeks
Discomfort/abdominal lower pain
Time frame: 12 weeks
emotional and behavioral symptoms
University Rovira i Virgili
Other
Nutritional Intervention in Children With ASD and/or ADHD: Randomized Controlled Trial With Probiotics.
Acronym: PRONED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03502239
ADHD, ASD
Toronto, Ontario, Canada
View Trial DetailsNCT04958460
ADHD, Attention Deficit Disorder with Hyperactivity
Kaohsiung City, Taiwan
View Trial DetailsNCT04178421
ADHD, ASD
Hong Kong
View Trial DetailsNCT07661823
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Richmond, Virginia, United States
View Trial Details